FDA Adverse Event Malfunction Summary report: N

INFINION CX

MDR report key: 15904651 · Received December 2, 2022

Report

Report Number
3006630150-2022-06697
Event Type
Malfunction
Date Received
December 2, 2022
Date of Event
February 25, 2022
Report Date
March 6, 2023
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION
Product Code
LGW
UDI-DI
08714729861638
PMA / PMN Number
P030017
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
ID, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENT INVOLVED IN THE EVENT: PRODUCT FAMILY: SCS-LINEAR LEADS. UPN: M365SC2317700. MODEL: SC-2317-70. SERIAL: (B)(6). BATCH: 7071930.

Additional Manufacturer Narrative · 0

EXACT DATE UNKNOWN, EVENT OCCURRED 2 WEEKS AGO FROM DATE MANUFACTURER WAS MADE AWARE.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENTS LEADS WERE FRACTURED. IT WAS ALSO NOTED THAT THE PATIENT WAS EXPERIENCING INADEQUATE STIMULATION DUE TO LEADS HAVING HIGH IMPEDANCES. ADDITIONAL INFORMATION WAS RECEIVED THAT LEAD FRACTURE WAS NOT CONFIRMED THROUGH X-RAY. ADDITIONAL INFORMATION WAS RECEIVED THAT THE PATIENT UNDERWENT A LEAD REPLACEMENT PROCEDURE AND WAS DOING WELL POSTOPERATIVELY.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENTS LEADS WERE FRACTURED. IT WAS ALSO NOTED THAT THE PATIENT WAS EXPERIENCING INADEQUATE STIMULATION DUE TO LEADS HAVING HIGH IMPEDANCES. ADDITIONAL INFORMATION WAS RECEIVED THAT LEAD FRACTURE WAS NOT CONFIRMED THROUGH X-RAY.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENTS LEADS WERE FRACTURED. IT WAS ALSO NOTED THAT THE PATIENT WAS EXPERIENCING INADEQUATE STIMULATION DUE TO LEADS HAD HIGH IMPEDANCES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1796609 INFINION CX STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF LGW BOSTON SCIENTIFIC NEUROMODULATION SC-2317-70 7070508 08714729861638

Patients

Seq Age Sex Outcome Treatment
1 32 YR Female Required Intervention